DISCOUNT ZERTIFIKAT - BECTON DICKINSON AND CO. Stock

Certificat

DE000MG1B344

Real-time Bid/Ask 13:04:49 2024-06-11 EDT
184.31 EUR / 184.39 EUR +0.04% Intraday chart for DISCOUNT ZERTIFIKAT - BECTON DICKINSON AND CO.
Current month+2.22%
1 month+1.50%
Date Price Change
24-06-11 184.8 +0.29%
24-06-10 184.3 +0.38%
24-06-07 183.6 +0.82%
24-06-06 182.1 +0.17%
24-06-05 181.8 +0.16%

Delayed Quote Börse Stuttgart

Last update June 11, 2024 at 10:45 am

More quotes

Static data

Product typeDiscount Certificates
Buy / SellCALL
Underlying BECTON, DICKINSON AND COMPANY
Issuer Morgan Stanley
WKN MG1B34
ISINDE000MG1B344
Date issued 2024-04-02
Maturity 2025-03-21 (283 Days)
Parity 1 : 1
Emission price 183.6
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 184.8
Lowest since issue 178.2
Spread 0.08
Spread %0.04%

Company Profile

Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical equipment (73.5%): surgical instruments, urological care products, pharmaceutical systems, etc.; - diagnostic materials (18.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, etc.; - clinical research and development tools (7.8%): tools for discovering drugs and vaccines, studying genes, culturing cells, and manipulating liquids, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (57.4%), Europe/Middle East/Africa (21.9%), Asia (15%) and other (5.7%).
Sector
-
More about the company

Ratings for Becton, Dickinson and Company

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Consensus: Becton, Dickinson and Company

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
239.5 USD
Average target price
278.7 USD
Spread / Average Target
+16.36%
Consensus